HomeCompareGOVXW vs NOBL

GOVXW vs NOBL: Dividend Comparison 2026

GOVXW yields 57142.86% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GOVXW wins by $1.8137199447430393e+24M in total portfolio value
10 years
GOVXW
GOVXW
● Live price
57142.86%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8137199447430393e+24M
Annual income
$1,807,497,607,342,771,000,000,000,000,000.00
Full GOVXW calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — GOVXW vs NOBL

📍 GOVXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGOVXWNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GOVXW + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GOVXW pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GOVXW
Annual income on $10K today (after 15% tax)
$4,857,142.86/yr
After 10yr DRIP, annual income (after tax)
$1,536,372,966,241,355,200,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, GOVXW beats the other by $1,536,372,966,241,355,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GOVXW + NOBL for your $10,000?

GOVXW: 50%NOBL: 50%
100% NOBL50/50100% GOVXW
Portfolio after 10yr
$9.068599723715196e+23M
Annual income
$903,748,803,671,385,500,000,000,000,000.00/yr
Blended yield
99.66%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GOVXW buys
0
NOBL buys
0
No recent congressional trades found for GOVXW or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGOVXWNOBL
Forward yield57142.86%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.8137199447430393e+24M$22.8K
Annual income after 10y$1,807,497,607,342,771,000,000,000,000,000.00$246.19
Total dividends collected$1.813311652454266e+24M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: GOVXW vs NOBL ($10,000, DRIP)

YearGOVXW PortfolioGOVXW Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$5,724,986$5,714,285.71$10,914$214.34+$5.71MGOVXW
2$3,063,527,985$3,057,402,250.62$11,897$218.63+$3063.52MGOVXW
3$1,532,308,824,967$1,529,030,850,022.66$12,952$222.72+$1532308.81MGOVXW
4$716,394,107,906,517$714,754,537,463,802.60$14,086$226.62+$716394107.89MGOVXW
5$313,071,475,901,711,400$312,304,934,206,251,460.00$15,302$230.33+$313071475901.70MGOVXW
6$127,886,778,198,343,160,000$127,551,791,719,128,320,000.00$16,607$233.85+$127886778198343.14MGOVXW
7$48,831,901,813,479,680,000,000$48,695,062,960,807,450,000,000.00$18,007$237.18+$48831901813479680.00MGOVXW
8$17,429,423,992,127,943,000,000,000$17,377,173,857,187,520,000,000,000.00$19,508$240.35+$17429423992127942656.00MGOVXW
9$5,815,268,598,381,736,000,000,000,000$5,796,619,114,710,159,000,000,000,000.00$21,116$243.35+$5.815268598381735e+21MGOVXW
10$1,813,719,944,743,039,200,000,000,000,000$1,807,497,607,342,771,000,000,000,000,000.00$22,841$246.19+$1.8137199447430393e+24MGOVXW

GOVXW vs NOBL: Complete Analysis 2026

GOVXWStock

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Full GOVXW Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this GOVXW vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GOVXW vs SCHDGOVXW vs JEPIGOVXW vs OGOVXW vs KOGOVXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.